MMedication Read More FDA Announces New Nationwide Blood Pressure Medication RecallSeptember 27, 2026 If you take blood pressure medication—or know someone who does—there’s a new recall you’ll want to know about.…
MMedication Read More Drug chain needs more checks, not fewer links, say pharmacists | Bengaluru NewsSeptember 26, 2026 Bengaluru: As Karnataka govt considers tightening the drug supply chain by enabling direct procurement between manufacturers and hospitals,…
MMedication Read More Thyroid Medication Recall Elevated to Highest Warning Level: FDASeptember 26, 2026 NEED TO KNOW The FDA has elevated the recall of a thyroid medication to Class I, due to…
HHealthcare Read More Loyal’s big-dog lifespan drug clears third FDA hurdleSeptember 23, 2026 LOY-003, a daily tablet for large and giant breeds, has earned RXE acceptance, the third such milestone for…
NNutrition Read More Those Viral Bodega Peptides Aren’t Actually PeptidesSeptember 15, 2026 The Mr. Green bodega sits on a busy stretch of Bedford Avenue in Brooklyn, New York. Near the…
MMedication Read More FDA Accepts & Gives Priority Review to Intellia’s BLA for HAE DrugSeptember 10, 2026 Intellia Therapeutics NTLA announced that the FDA has accepted the biologics license application (BLA) seeking approval for lonvoguran ziclumeran…
MMedication Read More FDA seizes medicines from Amazon facilities in Bengaluru RuralSeptember 7, 2026 BENGALURU: The Drugs Enforcement Wing of the Karnataka Food Safety and Drug Administration (FDA) has cracked down on…
MMedication Read More Ocular Therapeutix (OCUL): Faster Path To Approval Comes With Rising CostsSeptember 5, 2026 On August 3, Ocular Therapeutix (NASDAQ:OCUL) reported second-quarter 2026 financial results that read as much like a regulatory…
NNutrition Read More FDA warning over trendy longevity supplement after hospitalizationsAugust 31, 2026 The quest for longevity is leaving some in worse shape than when they started. The FDA has issued…
NNutrition Read More Beware the ‘unholy trinity’ of supplementsAugust 28, 2026 That bottle in your medicine cabinet may deserve a closer look. Nearly three-quarters of American adults take dietary…
MMedication Read More Misbranding, storage lapses: FDA cancels Cipla Pune unit’s drug licence over Reactin Plus violations | Mumbai NewsAugust 28, 2026 The Maharashtra Food and Drug Administration has revoked Cipla’s licenses to sell Reactin Plus Tablets MUMBAI: The Maharashtra…
MMedication Read More FDA Announces Recall of Thyroid Medicine Due to Potential “Super Potency”August 28, 2026 If you take medication for an underactive thyroid, check your bottle right away. The U.S. Food and Drug…